Flora Growth Corp. Faces Nasdaq Compliance Challenge Following Director's Passing

Reuters
Aug 28
<a href="https://laohu8.com/S/FLGC">Flora Growth Corp.</a> Faces Nasdaq Compliance Challenge Following Director's Passing

Flora Growth Corp., an Ontario-based company, has announced a regulatory compliance issue following the passing of Harold Wolkin, an Independent Director. Mr. Wolkin served on the company's audit, compensation, and nominating and corporate governance committees. His passing has left Flora Growth's board with only two Independent Directors out of four members, falling short of the majority required by Nasdaq Listing Rule 5605(b)(1). Additionally, the company's audit committee is now comprised of only two members, not meeting the minimum of three Independent Directors as per Nasdaq Listing Rule 5605(c)(2)$(A)$. Flora Growth is currently exploring options to regain compliance with these Nasdaq rules within the designated cure period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Flora Growth Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-25-015011), on August 27, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10